# Blood Pressure Lowering in Dialysis (BOLD) Trial

> **NCT03459807** · PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 50 (actual)

## Conditions studied

- Blood Pressure
- End Stage Renal Disease on Dialysis (Diagnosis)
- Chronic Kidney Diseases
- Chronic Kidney Disease Stage 5

## Interventions

- **DRUG:** Anti-Hypertensive medications
- **PROCEDURE:** Dry Weight Adjustment

## Key facts

- **NCT ID:** NCT03459807
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-23
- **Primary completion:** 2018-12-06
- **Final completion:** 2018-12-06
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-07-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03459807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03459807, "Blood Pressure Lowering in Dialysis (BOLD) Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03459807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*